Fiber alignment in 3D collagen networks as a biophysical marker for cell contractility.

Autor: Böhringer D; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address: david.boehringer@fau.de., Bauer A; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Moravec I; Novartis Institutes for BioMedical Research, Basel, Switzerland., Bischof L; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Kah D; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Mark C; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Grundy TJ; Children's Cancer Research Unit, The Children's Hospital at Westmead, University of Sydney, Australia., Görlach E; Novartis Institutes for BioMedical Research, Basel, Switzerland., O'Neill GM; Children's Cancer Research Unit, The Children's Hospital at Westmead, University of Sydney, Australia., Budday S; Department of Mechanical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Strissel PL; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Department of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Strick R; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Malandrino A; Department of Materials Science and Engineering, Universitat Politécnica de Catalunya, Barcelona, Spain., Gerum R; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Department of Physics and Astronomy, York University, Toronto, Canada., Mak M; Department of Biomedical Engineering, Yale University, New Haven, USA. Electronic address: michael.mak@yale.edu., Rausch M; Novartis Institutes for BioMedical Research, Basel, Switzerland., Fabry B; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: ben.fabry@fau.de.

Publikováno v: Matrix biology : journal of the International Society for Matrix Biology [Matrix Biol] 2023 Dec; Vol. 124, pp. 39-48. Date of Electronic Publication: 2023 Nov 14.

PAX8 and MECOM are interaction partners driving ovarian cancer.

Autor: Bleu M; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Mermet-Meillon F; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Apfel V; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Barys L; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Holzer L; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Bachmann Salvy M; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Lopes R; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Amorim Monteiro Barbosa I; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Delmas C; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Hinniger A; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Chau S; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Kaufmann M; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Haenni S; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Berneiser K; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Biozentrum, University of Basel, Basel, Switzerland., Wahle M; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Moravec I; Analytical Sciences and Imaging, Novartis Institutes for Biomedical Research, Basel, Switzerland., Vissières A; Analytical Sciences and Imaging, Novartis Institutes for Biomedical Research, Basel, Switzerland., Poetsch T; Analytical Sciences and Imaging, Novartis Institutes for Biomedical Research, Basel, Switzerland., Ahrné E; Analytical Sciences and Imaging, Novartis Institutes for Biomedical Research, Basel, Switzerland., Carte N; Analytical Sciences and Imaging, Novartis Institutes for Biomedical Research, Basel, Switzerland., Voshol J; Analytical Sciences and Imaging, Novartis Institutes for Biomedical Research, Basel, Switzerland., Bechter E; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Hamon J; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Meyerhofer M; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Erdmann D; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Fischer M; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Stachyra T; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Freuler F; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Gutmann S; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Fernández C; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Schmelzle T; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Naumann U; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Roma G; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Lawrenson K; Cedars-Sinai Women's Cancer Program at the Samuel Oschin Cancer Center, Los Angeles, CA, USA., Nieto-Oberhuber C; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland., Cobos-Correa A; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland., Ferretti S; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland., Schübeler D; Friedrich Miescher Institute for Biomedical Research, University of Basel, Basel, Switzerland.; Faculty of Science, University of Basel, Basel, Switzerland., Galli GG; Disease area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland. giorgio.galli@novartis.com.

Publikováno v: Nature communications [Nat Commun] 2021 Apr 26; Vol. 12 (1), pp. 2442. Date of Electronic Publication: 2021 Apr 26.

Insights into the Detoxification of Spruce Monoterpenes by the Eurasian Spruce Bark Beetle.

Autor: Naseer, Aisha¹ (AUTHOR) sellamuthu@fld.czu.cz, Singh, Vivek Vikram^1,2 (AUTHOR) synekj@fld.czu.cz, Sellamuthu, Gothandapani¹ (AUTHOR) mogilicherla@fld.czu.cz, Synek, Jiří¹ (AUTHOR), Mogilicherla, Kanakachari^1,3 (AUTHOR), Kokoska, Ladislav⁴ (AUTHOR) kokoska@ftz.czu.cz, Roy, Amit¹ (AUTHOR) roy@fld.czu.cz

Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p10209. 24p.

Conditions of natural regeneration of Norway spruce ecosystems in the Krkonose mountains

Autor: Cudlín, P., Godbold, D. L., Bonifacio, Eleonora, Egli, S., Fritz, H., Gonthier, Paolo, Chmelíková, E., Kowalik, P., Martinotti, M., Moravec, I., Nicolotti, Giovanni, Varese, Giovanna, Cristina, Peter, M., Zanini, Ermanno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::1b639e97c7e109d96485a19244f79784
http://hdl.handle.net/2318/22130

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.